How AstraZeneca’s Silence Led to a $4 Billion Loss Overnight


As rumors swirled about whether or not AstraZeneca Chief Executive Officer Pascal Soriot was leaving for Israel-based Teva Pharmaceutical, investors expressed their concerns with a sell off that cost the British company $4 billion overnight.
Source link